Catálogo de publicaciones - libros
Título de Acceso Abierto
Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
Cannabis sativa (Cannabis); cannabinoids; tetrahydrocannabinol (THC); cannabidiol (CBD); cannabinoid receptors (CB1 and CB2); Papaver somniferum (opium poppy); secondary metabolites; ursolic acid; NSCLC; tumorsphere; EGFR; STAT3; MMP2; PD-L1; MAFLD; tanshinone IIA; phytochemical; lipogenesis; lipid accumulation; LXRα; malaria; quinine; chloroquine; artemisinin; onchocerciasis; ivermectin; moxidectin; cancer; vincristine; vinblastine; anabolic; diabetes; Duchenne muscular dystrophy; β-ecdysone; ecdysteroid; ecdysterone; Mas1; osteoporosis; sarcopenia; COVID-19; cardiometabolic diseases; respiratory diseases; natural product; SARS-CoV-2; lung cancer; United States Food and Drug Administration-approved drug; natural remedy; triterpenoid; molecular ribbon; Huisgen 1,3-dipolar cycloaddition; amide bond; multifunctional PEG3 derivative; antimicrobial activity; anti-HIV activity; cytotoxicity; supramolecular self-assembly; phytocannabinoids; cannabichromene; thermos-TRPs; TRPA1; α,α-dimethylheptyl effect; betulinic acid; BODIPY; bevirimat; cell-cycle; fluorescent microscopy; maturation inhibitor; capsaicinoids; endocannabinoidome; microbiota; overweight; obesity; food intake; lipidomics; metabolism; alkaloids; membrane fusion; viral fusion inhibitor; antiviral therapy; curcumin; cancer cells; bioavailability; curcumin derivatives; curcumin analogues; curcumin delivery systems; natural product synthesis; lignans; inflammation; NF-κB inhibition; n/a
Disponibilidad
Institución detectada | Año de publicación | Navegá | Descargá | Solicitá |
---|---|---|---|---|
No requiere | Directory of Open access Books |
Información
Tipo de recurso:
libros
ISBN electrónico
978-3-0365-3882-2
País de edición
Suiza